CoChat

Microenvironment-responsive multifunctional enzyme-linked hydrogel for diabetic bone defect regeneration.

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 8 of the 20 sources its claims cite were checked for support.

Abstract

A glucose/ROS-responsive multifunctional hydrogel (AAT-ZCG) is designed, integrating tannic acid-mediated dynamic borate ester bonds and a cascade nanozyme comprising cerium-zoledronic acid-glucose oxidase. Acidic byproducts trigger ZCG degradation, releasing zoledronic acid to inhibit excessive osteoclast activation.

Overview

CoChat Summary

## TL;DR

This study developed a glucose/ROS-responsive hydrogel (AAT-ZCG) that combines tannic acid, a cerium-zoledronic acid-glucose oxidase nanozyme, and dynamic borate ester chemistry to address multiple pathological features of diabetic bone defects at once. In a rat diabetic cranial defect model, it reduced inflammation and osteoclast activity while promoting angiogenesis and bone regeneration, with RNA-seq implicating FoxO1/P53 signaling.

## Key findings

  • The ZCG multi-nanozyme was reported as ~50 nm spherical particles, with mixed cerium valence states of 56.18% Ce³⁺ and 43.82% Ce⁴⁺, supporting SOD- and CAT-like activity.
  • In glucose-response tests, ZCG acidified the medium as glucose increased; with 4 mg/mL glucose, pH dropped from 6.74 to 3.38 within 24 h, and H₂O₂ from glucose oxidation caused colloidal destabilization.
  • The AAT gel showed strong mechanics and self-healing: it withstood frequencies >50 Hz, strains up to 480%, had storage modulus >700, and healed to 800% stretch without breaking.
  • In vivo, the hydrogel degraded progressively, with 24.2% remaining at 7 days, 12.3% at 14 days, 7.7% at 21 days, and complete degradation by 42 days; in the rat diabetic cranial defect model, BV/TV improved to 0.49 ± 0.01 at 4 weeks and 0.67 ± 0.01 at 8 weeks in the AAT-ZCG group, outperforming the comparison groups.
  • The paper reports AAT-ZCG reduced inflammation and osteoclastogenesis, promoted M2 macrophage polarization, increased angiogenesis, and enhanced osteogenic markers; transcriptomics linked these effects to FoxO1 and P53/pP53 pathways.

## Methods

  • Design: Material synthesis and characterization of a dual-responsive hydrogel (AAT) loaded with a multi-nanozyme (ZCG), followed by in vitro functional assays and an in vivo diabetic rat cranial defect study.
  • Data/sample: Rat BMSCs, mouse BMDMs, HUVECs, and diabetic Sprague-Dawley rats with 5 mm diameter, 1 mm depth cranial defects; the animal study used groups including blank, AAT, AAT-GOx, AAT-ZC, and AAT-ZCG, with n = 4 rats per group per endpoint.
  • Main analysis: CCK8/live-dead cytocompatibility, osteogenic/osteoclast and macrophage polarization assays, ROS and angiogenesis assays, RNA-seq with GO/KEGG enrichment, molecular docking, siRNA knockdown of FoxO1, and in vivo Micro-CT, histology, and immunofluorescence; statistics used t-tests or ANOVA with P < 0.05.

## Limitations

  • The paper states it did not comprehensively explore the specific mechanisms of glucose regulation, especially at the systemic/global level.
  • It states immune regulation was mainly limited to macrophage polarization, and other immune cells such as T cells, B cells, or neutrophils were not thoroughly studied.
  • It states there was a lack of research on critical-sized large bone defects and that large animal models are needed for closer clinical relevance.
  • Evident from the text: several claims about in vivo efficacy are based on a rat cranial defect model, so generalizability to other defect types or species is not directly established in the paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-025-65165-5

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Schematic illustration of the construction and application of all-in-one microenvironment-responsive multifunctional enzyme-linked hydrogel.
Fig. 1 Schematic illustration of the construction and application of all-in-one microenvironment-responsive multifunctional enzyme-linked hydrogel.CC BY-NC-ND · PubMed Central
Fig. 2 Synthesis and characterization of ZCG. A, B Transmission electron microscope image of ZCG. C Atomic force scanning microscope image of ZCG. D Scanning electron microscope image of ZCG. E, F Fourier infrared spectroscopy analysis of ZCG. G X-ray photoelectron spectroscopy fitting results of ZCG. H Schematic diagram of the catalytic clearance of glucose by ZCG multi-nanozyme. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). I Characterization of glucose catalytic ability of ZCG, n = 3. J UV-visible light absorption spectrum. K Schematic diagram of ZCG multi-nanozyme catalytic clearance of H2O2. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). L Characterization of the ability of ZCG to simulate catalase, n = 3. Figure 2I, L involved three biological replications (n = 3) and data were presented as mean ± SD.
Fig. 2 Synthesis and characterization of ZCG. A, B Transmission electron microscope image of ZCG. C Atomic force scanning microscope image of ZCG. D Scanning electron microscope image of ZCG. E, F Fourier infrared spectroscopy analysis of ZCG. G X-ray photoelectron spectroscopy fitting results of ZCG. H Schematic diagram of the catalytic clearance of glucose by ZCG multi-nanozyme. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). I Characterization of glucose catalytic ability of ZCG, n = 3. J UV-visible light absorption spectrum. K Schematic diagram of ZCG multi-nanozyme catalytic clearance of H2O2. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). L Characterization of the ability of ZCG to simulate catalase, n = 3. Figure 2I, L involved three biological replications (n = 3) and data were presented as mean ± SD.CC BY-NC-ND · PubMed Central
Fig. 3 Synthesis and characterization of AAT-ZCG gel. A–C Rheological characterization of AAT hydrogels. D, E Self-healing and stretchability characterization of AAT hydrogels. F AAT hydrogel adhesion characterization. G The structure of AAT hydrogel was characterized by cryo-electron microscopy. H Disintegration and release characteristics of AAT hydrogels, n = 3. I Characterization of ROS clearance performance of AAT-ZCG immunoregulatory hydrogels, n = 3. Figure 3H, I involved three biological replications (n = 3) and data were presented as mean ± SD. In the 2I box diagram, the upper edge line of the box whiskers represents the maximum value, the lower boundary represents the minimum value, and the hollow square represents the average value.
Fig. 3 Synthesis and characterization of AAT-ZCG gel. A–C Rheological characterization of AAT hydrogels. D, E Self-healing and stretchability characterization of AAT hydrogels. F AAT hydrogel adhesion characterization. G The structure of AAT hydrogel was characterized by cryo-electron microscopy. H Disintegration and release characteristics of AAT hydrogels, n = 3. I Characterization of ROS clearance performance of AAT-ZCG immunoregulatory hydrogels, n = 3. Figure 3H, I involved three biological replications (n = 3) and data were presented as mean ± SD. In the 2I box diagram, the upper edge line of the box whiskers represents the maximum value, the lower boundary represents the minimum value, and the hollow square represents the average value.CC BY-NC-ND · PubMed Central
Fig. 4 Evaluation of the osteogenic promoting effect of AAT-ZCG in vitro. A AAT-ZCG promotes bone activity characterization. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). B, C Alizarin red staining and analysis of BMSCs treated with AAT-ZCG. D, E Alkaline phosphatase staining and analysis of BMSCs treated with AAT-ZCG. F, G BMP2 immunofluorescence staining and analysis. Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Green: F-actin, Ex: 488 nm, endow with pseudo-color: RGB (0, 255, 0); Red: BMP2, Ex: 561 nm, endow with pseudo-color: RGB (255, 0, 0). H, I Runx2 immunofluorescence staining and analysis. Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Green: F-actin, Ex: 488 nm, endow with pseudo-color: RGB (0, 255, 0); Red: Runx2, Ex: 561 nm, endow with pseudo-color: RGB (255, 0, 0). The expression of osteogenic genes was verified by q-PCR, J Spp1, K Bglap, L BMP2, M) Sp7. Data are presented as mean ± SD. Figure 4C, E, G, I–M involved three biological replications (n = 3) and analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference. Specific P-values are shown in the source data. Source data are provided as source data files. BMSCs Bone mesenchymal stem cells, BMP2 Bone morphogenetic protein 2, Bglap osteocalcin, Spp1 osteopontin, Sp7 osterix.
Fig. 4 Evaluation of the osteogenic promoting effect of AAT-ZCG in vitro. A AAT-ZCG promotes bone activity characterization. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). B, C Alizarin red staining and analysis of BMSCs treated with AAT-ZCG. D, E Alkaline phosphatase staining and analysis of BMSCs treated with AAT-ZCG. F, G BMP2 immunofluorescence staining and analysis. Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Green: F-actin, Ex: 488 nm, endow with pseudo-color: RGB (0, 255, 0); Red: BMP2, Ex: 561 nm, endow with pseudo-color: RGB (255, 0, 0). H, I Runx2 immunofluorescence staining and analysis. Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Green: F-actin, Ex: 488 nm, endow with pseudo-color: RGB (0, 255, 0); Red: Runx2, Ex: 561 nm, endow with pseudo-color: RGB (255, 0, 0). The expression of osteogenic genes was verified by q-PCR, J Spp1, K Bglap, L BMP2, M) Sp7. Data are presented as mean ± SD. Figure 4C, E, G, I–M involved three biological replications (n = 3) and analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference. Specific P-values are shown in the source data. Source data are provided as source data files. BMSCs Bone mesenchymal stem cells, BMP2 Bone morphogenetic protein 2, Bglap osteocalcin, Spp1 osteopontin, Sp7 osterix.CC BY-NC-ND · PubMed Central
Fig. 5 Evaluation of AAT-ZCG’s ability to inhibit osteoclasts in vitro. A The osteoclastic inhibitory effect of AAT-ZCG. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). B Observation of osteoclast formation after AAT-ZCG treatment. Scale bar: 100 μM. Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Red: F-actin, Ex: 561 nm, endow with pseudo-color: RGB (255, 128, 0); C Quantitative measurement of osteoclast area. q-PCR was used to characterize the expression of osteoclast-related genes (D) Acp5, E NFATc1, F MMP9. Data are presented as mean ± SD. Figure 5C–F involved three biological replications (n = 3) and analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference. Acp5: Acid Phosphatase 5, NFATc1: Nuclear Factor of Activated T-Cells, c-Fos: Fos proto-oncogene, MMP9: Matrix metallopeptidase 9.
Fig. 5 Evaluation of AAT-ZCG’s ability to inhibit osteoclasts in vitro. A The osteoclastic inhibitory effect of AAT-ZCG. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). B Observation of osteoclast formation after AAT-ZCG treatment. Scale bar: 100 μM. Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Red: F-actin, Ex: 561 nm, endow with pseudo-color: RGB (255, 128, 0); C Quantitative measurement of osteoclast area. q-PCR was used to characterize the expression of osteoclast-related genes (D) Acp5, E NFATc1, F MMP9. Data are presented as mean ± SD. Figure 5C–F involved three biological replications (n = 3) and analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference. Acp5: Acid Phosphatase 5, NFATc1: Nuclear Factor of Activated T-Cells, c-Fos: Fos proto-oncogene, MMP9: Matrix metallopeptidase 9.CC BY-NC-ND · PubMed Central
Fig. 6 Characterization of AAT-ZCG regulating immune polarization and promoting angiogenesis in vitro. A Cell polarization was characterized by flow cytometry. B Quantitative regulation of Raw 264.7 polarization ability by AAT-ZCG. C Schematic diagram of Transwell assay for evaluating cell migration. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). D Quantification of migrating cells in Transwell assay. E Bright-field photographs of migrated cells in the Transwell assay. F, G Evaluation of promoting angiogenesis of AAT-ZCG in vitro. H DCFH-DA fluorescent staining was used to characterize the ROS clearance effect of AAT-ZCG. Scale bar, 100 μm, Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Green: DCFH-DA, excitation wavelength (Ex): 488 nm, RGB (0, 255, 0). Data are presented as mean ± SD. Figure 6B, D G involved three biological replications (n = 3) and analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference. Raw 264.7: Mouse Monocytic Macrophage Leukemia Cell Line, DCFH-DA: 2′,7′-Dichlorodihydrofluorescein Diacetate, ROS Reactive oxygen species.
Fig. 6 Characterization of AAT-ZCG regulating immune polarization and promoting angiogenesis in vitro. A Cell polarization was characterized by flow cytometry. B Quantitative regulation of Raw 264.7 polarization ability by AAT-ZCG. C Schematic diagram of Transwell assay for evaluating cell migration. Created in BioRender. Chen, (https://BioRender.com/7n6p5gi). D Quantification of migrating cells in Transwell assay. E Bright-field photographs of migrated cells in the Transwell assay. F, G Evaluation of promoting angiogenesis of AAT-ZCG in vitro. H DCFH-DA fluorescent staining was used to characterize the ROS clearance effect of AAT-ZCG. Scale bar, 100 μm, Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Green: DCFH-DA, excitation wavelength (Ex): 488 nm, RGB (0, 255, 0). Data are presented as mean ± SD. Figure 6B, D G involved three biological replications (n = 3) and analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference. Raw 264.7: Mouse Monocytic Macrophage Leukemia Cell Line, DCFH-DA: 2′,7′-Dichlorodihydrofluorescein Diacetate, ROS Reactive oxygen species.CC BY-NC-ND · PubMed Central
Fig. 7 Functional and mechanistic insights of AAT-ZCG for DM bone defects in regulating FoxO1/P53 signaling pathways. A Volcano plot showing differentially expressed genes (DEGs) between experimental and control groups. Red dots indicate up-regulated genes, and blue dots indicate down-regulated genes. B Gene Ontology (GO) enrichment analysis of up-regulated genes. C GO enrichment analysis of down-regulated genes. D Heatmap of the expression levels of DEGs across experimental groups, with specific key genes like FoxO1 highlighted. E Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis of DEGs, identifying significant pathways such as P53 signaling, FoxO1 signaling. F Schematic diagram illustrates the proposed mechanism of AAT-ZCG in activating the forkhead box O1 (FoxO1) and P53 pathways. G Western blot was conducted to evaluate the effects of AAT-ZCG on inflammation and osteogenesis through the FoxO1/P53 signaling pathway. H The effect of AAT-ZCG on the expression of FoxO1, n = 3. I The effect of AAT-ZCG on P53 expression, n = 3. J The effect of AAT-ZCG on the expression of pP53, n = 3. K The effect of AAT-ZCG on the expression of MMP13, n = 3. L The effect of AAT-ZCG on the expression of BMP2, n = 3. M) The effect of AAT-ZCG on the expression of Acp5, n = 3. Data are presented as mean ± SD. Figure 7H-M involved three biological replications (n = 3) and analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. Statistical significance is indicated as follows: P < 0.05; P < 0.01*; P < 0.001***. Data are represented as mean ± SD from at least three independent experiments.
Fig. 7 Functional and mechanistic insights of AAT-ZCG for DM bone defects in regulating FoxO1/P53 signaling pathways. A Volcano plot showing differentially expressed genes (DEGs) between experimental and control groups. Red dots indicate up-regulated genes, and blue dots indicate down-regulated genes. B Gene Ontology (GO) enrichment analysis of up-regulated genes. C GO enrichment analysis of down-regulated genes. D Heatmap of the expression levels of DEGs across experimental groups, with specific key genes like FoxO1 highlighted. E Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis of DEGs, identifying significant pathways such as P53 signaling, FoxO1 signaling. F Schematic diagram illustrates the proposed mechanism of AAT-ZCG in activating the forkhead box O1 (FoxO1) and P53 pathways. G Western blot was conducted to evaluate the effects of AAT-ZCG on inflammation and osteogenesis through the FoxO1/P53 signaling pathway. H The effect of AAT-ZCG on the expression of FoxO1, n = 3. I The effect of AAT-ZCG on P53 expression, n = 3. J The effect of AAT-ZCG on the expression of pP53, n = 3. K The effect of AAT-ZCG on the expression of MMP13, n = 3. L The effect of AAT-ZCG on the expression of BMP2, n = 3. M) The effect of AAT-ZCG on the expression of Acp5, n = 3. Data are presented as mean ± SD. Figure 7H-M involved three biological replications (n = 3) and analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. Statistical significance is indicated as follows: P < 0.05; P < 0.01*; P < 0.001***. Data are represented as mean ± SD from at least three independent experiments.CC BY-NC-ND · PubMed Central
Fig. 8 Evaluation of therapeutic effect of AAT-ZCG in vivo. A, B Disintegration of AAT-ZCG in diabetic rats characterized by in vivo imaging of small animals. C CT images of diabetic cranial defect rats at 4 weeks and 8 weeks in different treatment groups. D BV/TV results of each treatment group at 8 weeks. E BS/BV results of each treatment group at 8 weeks. F Histological analysis by hematoxylin and eosin (H&E) staining and massion staining at 8 weeks. G Immunofluorescence staining of Runx2 and BMP2 at 8 weeks. H, I 8 weeks Runx2 and BMP2 immunofluorescence staining relative fluorescence intensity quantification. Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Green: BMP2, Ex: 488 nm, endow with pseudo-color: RGB (0, 255, 0); Red: Runx2, Ex: 640 nm, endow with pseudo-color: RGB (255, 0, 0). Data are presented as mean ± SD. Figure 8B involved three biological replications (n = 3), Fig. 8D-E, H-I involved four biological replications (n = 4). Analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference. BV Bone volume, TV Total volume, BS Bone surface, BMP2 Bone morphogenetic protein 2, RUNX2 Runt-related transcription factor 2, CT CT number.
Fig. 8 Evaluation of therapeutic effect of AAT-ZCG in vivo. A, B Disintegration of AAT-ZCG in diabetic rats characterized by in vivo imaging of small animals. C CT images of diabetic cranial defect rats at 4 weeks and 8 weeks in different treatment groups. D BV/TV results of each treatment group at 8 weeks. E BS/BV results of each treatment group at 8 weeks. F Histological analysis by hematoxylin and eosin (H&E) staining and massion staining at 8 weeks. G Immunofluorescence staining of Runx2 and BMP2 at 8 weeks. H, I 8 weeks Runx2 and BMP2 immunofluorescence staining relative fluorescence intensity quantification. Blue: DAPI, excitation wavelength (Ex): 405 nm, endow with pseudo-color: RGB (0, 0, 255); Green: BMP2, Ex: 488 nm, endow with pseudo-color: RGB (0, 255, 0); Red: Runx2, Ex: 640 nm, endow with pseudo-color: RGB (255, 0, 0). Data are presented as mean ± SD. Figure 8B involved three biological replications (n = 3), Fig. 8D-E, H-I involved four biological replications (n = 4). Analysis of these experiments’ results were performed using one-way ANOVA. ns, no statistical significance. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference. BV Bone volume, TV Total volume, BS Bone surface, BMP2 Bone morphogenetic protein 2, RUNX2 Runt-related transcription factor 2, CT CT number.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 6 Not checked · 88 Own results and interpretations

42 more claims

Create a free account to see all 100 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 48
  • The quote only partly states this claim. 4
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Citations

Cites

Show all 36 references

Cited by

See all 44

Metadata

Authors
Fu, X., Luo, Z., Guo, Y., Meng, W., Jin, S., Chen, J., Cai, Y., Luo, Z., Huang, C., Chen, A., Guo, S., Chen, M., Zhou, Z., & Zeng, W.
Affiliations
  • Sichuan University (CN)
  • Chinese People's Liberation Army (CN)
Corresponding author
  • Zhou, Zongke
  • Zeng, Weinan
Venue
Nature Communications
Published
2025-11-21
Volume
16
Issue
1
Pages
10275-10275
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4416470470
Cited by
44
References
29
Citations by year
2026: 44
FWCI
10.63
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (82272483, 82472430)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
Keywords
diabetic bone defects, hydrogels, glucose-responsive release, reactive oxygen species scavenging, nanozymes, tannic acid, borate ester bonds, glucose oxidase, cerium, zoledronic acid, macrophage polarization, angiogenesis, bone formation, osteoclast inhibition, FOXO1, bone regeneration, inflammation
MeSH terms
RAW 264.7 Cells, Zoledronic Acid, Animals, Bone Regeneration, Cerium, Diabetes Mellitus, Experimental, Glucose, Glucose Oxidase, Humans, Macrophages, Male, Mice, Inbred C57BL, Osteogenesis, Tannins, Reactive Oxygen Species, Hydrogels, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microenvironment-responsive multifunctional enzyme-linked hydrogel for diabetic bone defect regeneration. https://app.cochat.ai/papers/10.1038/s41467-025-65165-5
The paper
Fu, X., Luo, Z., Guo, Y., Meng, W., Jin, S., Chen, J., Cai, Y., Luo, Z., Huang, C., Chen, A., Guo, S., Chen, M., Zhou, Z., & Zeng, W. (2025). Microenvironment-responsive multifunctional enzyme-linked hydrogel for diabetic bone defect regeneration. Nature Communications. https://doi.org/10.1038/s41467-025-65165-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.